What does low VLDL mean?

Low VLDL cholesterol (under 10 mg/dL) is generally positive for heart health but can sometimes indicate underlying issues like malnutrition or liver problems. Most people with low VLDL have no symptoms and benefit from reduced cardiovascular risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding VLDL Cholesterol

Very low-density lipoprotein (VLDL) is one of the five major types of lipoproteins that transport cholesterol and triglycerides through your bloodstream. Think of VLDL as a delivery truck that carries triglycerides (fats) from your liver to tissues throughout your body. While you've probably heard more about LDL (bad cholesterol) and HDL (good cholesterol), VLDL plays a crucial role in your cardiovascular health.

Your liver produces VLDL particles, which are rich in triglycerides. As these particles travel through your bloodstream and deliver their triglyceride cargo to cells, they gradually transform into LDL cholesterol. This transformation is why VLDL is sometimes called a precursor to LDL cholesterol. Understanding your VLDL levels provides valuable insight into your metabolic health and cardiovascular risk profile.

Normal vs. Low VLDL Ranges

VLDL cholesterol typically isn't measured directly in standard lipid panels. Instead, it's calculated using the Friedewald equation: VLDL = Triglycerides ÷ 5 (when triglycerides are under 400 mg/dL). Normal VLDL levels range from 10 to 30 mg/dL, with optimal levels being at the lower end of this range. Low VLDL is generally considered anything below 10 mg/dL, though some labs may use slightly different reference ranges.

VLDL Cholesterol Levels and Clinical Significance

VLDL Level (mg/dL)CategoryHealth ImplicationsRecommended Action
Below 5<5 mg/dLVery LowMay indicate malnutrition, malabsorption, or hyperthyroidismEvaluate for underlying causes
5-105-10 mg/dLLowGenerally indicates excellent cardiovascular healthMaintain healthy lifestyle
10-3010-30 mg/dLNormalHealthy range with good cardiovascular risk profileContinue preventive measures
Above 30>30 mg/dLHighIncreased cardiovascular risk, often with high triglyceridesLifestyle changes, possible medication

VLDL levels should be interpreted alongside triglycerides, other lipid markers, and overall health status.

The Connection Between VLDL and Triglycerides

Since VLDL particles are primarily composed of triglycerides (about 60-70% of their content), your VLDL levels directly correlate with your triglyceride levels. When you have low triglycerides, you'll typically have low VLDL as well. This relationship is so consistent that most labs estimate VLDL based on your triglyceride measurement rather than measuring it directly.

Is Low VLDL Good or Bad?

In most cases, low VLDL cholesterol is a positive finding that indicates a lower risk of cardiovascular disease. Since VLDL particles contribute to the buildup of plaque in your arteries (atherosclerosis), having fewer of these particles circulating in your blood generally means less risk of heart attacks, strokes, and other cardiovascular events.

However, extremely low VLDL levels can sometimes signal underlying health issues that need attention. While rare, very low levels might indicate problems with liver function, malnutrition, or certain genetic conditions. The key is understanding the context of your overall health picture, including other biomarkers, symptoms, and medical history.

Benefits of Low VLDL

  • Reduced risk of atherosclerosis and arterial plaque buildup
  • Lower likelihood of developing heart disease and stroke
  • Better overall metabolic health
  • Improved insulin sensitivity
  • Less inflammation in blood vessels
  • Better response to dietary and lifestyle interventions

When Low VLDL Might Be Concerning

While low VLDL is typically beneficial, extremely low levels (especially when accompanied by other abnormal lab results) might indicate:

  • Malabsorption disorders affecting fat absorption
  • Severe malnutrition or eating disorders
  • Hyperthyroidism (overactive thyroid)
  • Certain liver diseases affecting lipid production
  • Rare genetic conditions affecting lipid metabolism

Common Causes of Low VLDL

Understanding what drives your VLDL levels lower can help you determine whether your results reflect healthy lifestyle choices or potential health concerns. Most commonly, low VLDL results from positive lifestyle factors, but certain medical conditions and medications can also play a role.

Lifestyle Factors

The most common and healthiest reasons for low VLDL include:

  • Following a low-fat or Mediterranean-style diet
  • Regular aerobic exercise and physical activity
  • Maintaining a healthy body weight
  • Limiting alcohol consumption
  • Avoiding refined sugars and processed foods
  • Intermittent fasting or time-restricted eating
  • Consuming omega-3 fatty acids from fish or supplements

Medical Conditions

Several medical conditions can lead to low VLDL levels:

  • Hyperthyroidism: An overactive thyroid speeds up metabolism, reducing lipid levels
  • Malabsorption syndromes: Conditions like celiac disease or Crohn's disease affecting fat absorption
  • Liver disease: Advanced liver disease can impair VLDL production
  • Genetic disorders: Rare conditions like abetalipoproteinemia or hypobetalipoproteinemia
  • Severe infections or inflammatory conditions
  • Cancer or cancer treatments affecting metabolism

Medications and Supplements

Certain medications and supplements can lower VLDL levels:

  • Statins (cholesterol-lowering medications)
  • Fibrates (specifically target triglycerides)
  • Niacin (vitamin B3) in therapeutic doses
  • Fish oil supplements high in EPA and DHA
  • Some diabetes medications like metformin
  • Thyroid hormone replacement (in hypothyroid patients)

Symptoms and Health Implications

Low VLDL cholesterol itself typically doesn't cause any noticeable symptoms. Most people discover they have low VLDL during routine blood work or when investigating other health concerns. However, if low VLDL is caused by an underlying condition, you might experience symptoms related to that specific issue.

Potential Symptoms of Underlying Causes

If your low VLDL is due to a medical condition, you might experience:

  • Unexplained weight loss (hyperthyroidism, malabsorption)
  • Chronic diarrhea or fatty stools (malabsorption disorders)
  • Fatigue and weakness (various conditions)
  • Heat intolerance and rapid heartbeat (hyperthyroidism)
  • Abdominal pain or bloating (digestive disorders)
  • Skin changes or rashes (nutritional deficiencies)

Long-term Health Considerations

While low VLDL generally indicates good cardiovascular health, extremely low levels might affect:

  • Fat-soluble vitamin absorption (vitamins A, D, E, K)
  • Hormone production (some hormones require cholesterol)
  • Cell membrane integrity
  • Brain function (cholesterol is important for neural health)
  • Immune system function

It's important to note that these concerns typically only arise with extremely low levels or when accompanied by deficiencies in other lipids. For most people with low VLDL, the cardiovascular benefits far outweigh any potential risks.

Testing and Monitoring Your VLDL

VLDL cholesterol is typically assessed as part of a comprehensive lipid panel, which measures various types of cholesterol and triglycerides in your blood. Since VLDL isn't usually measured directly, understanding how it's calculated and what other markers to monitor is essential for getting a complete picture of your cardiovascular health. Regular monitoring through at-home testing can help you track changes over time and assess how lifestyle modifications affect your levels.

How VLDL is Measured

Most laboratories calculate VLDL using the Friedewald equation: VLDL = Triglycerides ÷ 5. This calculation is accurate when triglycerides are below 400 mg/dL and you've fasted for 9-12 hours before the test. Some advanced lipid tests can directly measure VLDL particles, but these are less common and typically reserved for complex cases.

When evaluating your VLDL levels, it's important to consider other cardiovascular biomarkers:

  • Triglycerides: Directly related to VLDL levels
  • LDL cholesterol: The primary driver of atherosclerosis
  • HDL cholesterol: Protective cholesterol that removes excess lipids
  • Total cholesterol: Overall cholesterol burden
  • ApoB: Measures all atherogenic particles, including VLDL
  • Lipoprotein(a): Independent cardiovascular risk factor
  • High-sensitivity CRP: Marker of inflammation

Testing Frequency

For most adults with low VLDL and no other risk factors, annual testing is sufficient. However, more frequent monitoring every 3-6 months may be beneficial if you're:

  • Making significant dietary or lifestyle changes
  • Taking medications that affect lipid levels
  • Managing other cardiovascular risk factors
  • Monitoring an underlying condition that affects lipids
  • Working to optimize your metabolic health

Managing and Optimizing Your VLDL Levels

If your VLDL is low due to healthy lifestyle choices, maintaining those habits is key. However, if your levels are extremely low or you're experiencing symptoms, working with a healthcare provider to identify and address any underlying causes is important. Here's how to approach VLDL management based on your specific situation.

For Healthy Low VLDL

If your low VLDL reflects good metabolic health, continue with:

  • Balanced nutrition with emphasis on whole foods
  • Regular physical activity (150+ minutes per week)
  • Stress management techniques
  • Adequate sleep (7-9 hours nightly)
  • Moderate alcohol consumption or abstinence
  • Regular health monitoring

Addressing Extremely Low VLDL

If your VLDL is extremely low (under 5 mg/dL) or accompanied by other concerning symptoms:

  • Consult with a healthcare provider for comprehensive evaluation
  • Consider testing for thyroid function, liver enzymes, and nutritional markers
  • Evaluate medication effects with your doctor
  • Ensure adequate caloric and fat intake
  • Address any malabsorption issues
  • Monitor fat-soluble vitamin levels

Dietary Considerations

While low VLDL is generally positive, ensuring balanced nutrition is important:

  • Include healthy fats from sources like olive oil, avocados, and nuts
  • Consume adequate protein for hormone and enzyme production
  • Focus on nutrient-dense foods to prevent deficiencies
  • Consider supplementing fat-soluble vitamins if absorption is impaired
  • Work with a registered dietitian if you have specific concerns

The Bottom Line on Low VLDL

Low VLDL cholesterol is typically a sign of good cardiovascular health and effective metabolic function. For most people, it reflects positive lifestyle choices like healthy eating, regular exercise, and maintaining a healthy weight. The reduced risk of heart disease and stroke associated with low VLDL makes it a desirable goal for cardiovascular health optimization.

However, context matters. Extremely low levels, especially when accompanied by other abnormal lab results or symptoms, warrant further investigation. The key is understanding your complete health picture through comprehensive testing and working with healthcare providers when needed.

Remember that VLDL is just one piece of your cardiovascular health puzzle. Monitoring it alongside other lipid markers, inflammatory indicators, and metabolic health biomarkers provides the most complete picture of your health status. Regular testing, whether through your healthcare provider or convenient at-home options, empowers you to track your progress and make informed decisions about your health.

If you have low VLDL due to healthy lifestyle choices, celebrate this achievement and continue your positive habits. If you're concerned about extremely low levels or have symptoms suggesting an underlying condition, don't hesitate to seek medical evaluation. With the right approach, you can maintain optimal VLDL levels that support your long-term health and longevity goals.

References

  1. Nordestgaard, B. G., & Varbo, A. (2014). Triglycerides and cardiovascular disease. The Lancet, 384(9943), 626-635.[Link][DOI]
  2. Miller, M., Stone, N. J., Ballantyne, C., et al. (2011). Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 123(20), 2292-2333.[Link][PubMed]
  3. Ginsberg, H. N., Packard, C. J., Chapman, M. J., et al. (2021). Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies. European Heart Journal, 42(47), 4791-4806.[Link][PubMed][DOI]
  4. Hegele, R. A., Ginsberg, H. N., Chapman, M. J., et al. (2014). The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. The Lancet Diabetes & Endocrinology, 2(8), 655-666.[PubMed][DOI]
  5. Berglund, L., Brunzell, J. D., Goldberg, A. C., et al. (2012). Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 97(9), 2969-2989.[Link][PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my VLDL at home?

You can test your VLDL at home with SiPhox Health's Ultimate 360 Health Program, which includes VLDL testing along with 49 other biomarkers. This CLIA-certified program calculates your VLDL from triglyceride measurements and provides comprehensive cardiovascular health insights from the comfort of your home.

What is the optimal VLDL cholesterol range?

The normal VLDL range is 10-30 mg/dL, with optimal levels being at the lower end. Low VLDL is generally below 10 mg/dL. Since VLDL is calculated from triglycerides (VLDL = Triglycerides ÷ 5), keeping triglycerides under 150 mg/dL typically ensures healthy VLDL levels.

Can VLDL be too low?

While low VLDL is usually beneficial for heart health, extremely low levels (under 5 mg/dL) might indicate malnutrition, malabsorption disorders, hyperthyroidism, or liver problems. If you have very low VLDL with other symptoms, consult a healthcare provider for evaluation.

How can I maintain healthy low VLDL levels?

Maintain low VLDL through regular exercise, a diet low in refined sugars and processed foods, limiting alcohol, managing stress, and maintaining a healthy weight. Focus on whole foods, lean proteins, and healthy fats while avoiding trans fats and excessive simple carbohydrates.

What's the difference between VLDL and LDL cholesterol?

VLDL (very low-density lipoprotein) carries triglycerides from your liver to tissues and contains about 60-70% triglycerides. As VLDL delivers its triglyceride cargo, it transforms into LDL (low-density lipoprotein), which primarily carries cholesterol. Both contribute to cardiovascular risk, but through different mechanisms.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details